3Tarif N,Alwakeel JS,Mitwalli AH,et al.Serum cystatin C as amarker of renal function in patients with acute renal failure[J].Saudi J Kidney Dis Transpl,2008,19(6):918-923.
4Devarajan P,Williams LM.Proteomics for biomarker discovery inacute kidney injury[J].Semin Nephrol,2007,27(6):637-651.
5Stevens LA,Coresh J,Schmid CH,et al.Estimating GFR usingserum cystatin C alone and in combination with serum ereatinine:a pooled analysis of 3418 individuals with CKD[J].Am J KidneyDis,2008,51(3):395-406.
6Shinkai S,Chaves PH,Fujiwara Y,et al.Beta2-mi-croglobulin forrisk stratificatoin of total mortlity in the eldly population:comparison with Cystatin C and C-reactive protein[J].Arch Internmed,2008,168(2):200-206.
7Ikee R,kobayashi S,Hemmi N,et al.Involvement of transglutaminase-2in pathological changes in renal disease[J].Nephronclin Pract,2007,105(3):139-146.
8Kehrl JH, Wakefield LM, Roberts AB, et al. Production of transforming growth factor beta by human T lymphocyte sand its potential role in the regulation of T cell growth. J Exp Med, 1986,163:1037-1050.
9Suthanthiran M, Li B, Song JO, et al. Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: a novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci U S A, 2000, 97 : 3479-3484.
10Langdahl BL, Carstens M, Stenkjaer L. et al. Polymorphisms in the transforming growth factor beta 1 gene and osteoporosis. J Bone,2003,32:297- 310.
